Search hospitals > Iowa > Iowa City
University of Iowa/Holden Comprehensive Cancer Center
Claim this profileIowa City, Iowa 52242
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Recurrence
Conducts research for Lymphoma
Conducts research for Tumors
639 reported clinical trials
42 medical researchers
Summary
University of Iowa/Holden Comprehensive Cancer Center is a medical facility located in Iowa City, Iowa. This center is recognized for care of Cancer, Leukemia, Recurrence, Lymphoma, Tumors and other specialties. University of Iowa/Holden Comprehensive Cancer Center is involved with conducting 639 clinical trials across 638 conditions. There are 42 research doctors associated with this hospital, such as David S. Dickens, Mariko Sato, Muhammad Furqan, and Yousef Zakharia, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Leukemia
Global LeaderStage II
Stage I
CD5 positive
Top PIs
David S. DickensUniversity of Iowa/Holden Comprehensive Cancer Center9 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
63 reported clinical trials
121 drugs studied
Mariko SatoUniversity of Iowa/Holden Comprehensive Cancer Center7 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
49 reported clinical trials
95 drugs studied
Muhammad FurqanUniversity of Iowa Healthcare Cancer Services Quad Cities5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
20 reported clinical trials
35 drugs studied
Yousef Zakharia, MDUniversity of Iowa Hospitals and Clinics2 years of reported clinical research
Studies Cancer
Studies Renal Cell Carcinoma
19 reported clinical trials
45 drugs studied
Clinical Trials running at University of Iowa/Holden Comprehensive Cancer Center
Gastroesophageal Junction Adenocarcinoma
Brain Tumor
Gastric Cancer
Lymphoma
Non-Hodgkin's Lymphoma
Acute Leukemia
Osteosarcoma
Germ Cell Tumors
Cancer
Acute Lymphoblastic Leukemia
Ramucirumab + Trifluridine/Tipiracil or Paclitaxel
for Gastric Cancer
This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction cancer that has spread to other places in the body (advanced). Ramucirumab may damage tumor cells by targeting new blood vessel formation. Trifluridine/tipiracil is a chemotherapy pill and that may damage tumor cells by damaging their deoxyribonucleic acid (DNA). Paclitaxel may block cell growth by stopping cell division which may kill tumor cells. Giving ramucirumab and trifluridine/tipiracil will not be worse than ramucirumab and paclitaxel in treating gastric or gastroesophageal junction cancer.
Recruiting1 award Phase 21 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Iowa/Holden Comprehensive Cancer Center?
University of Iowa/Holden Comprehensive Cancer Center is a medical facility located in Iowa City, Iowa. This center is recognized for care of Cancer, Leukemia, Recurrence, Lymphoma, Tumors and other specialties. University of Iowa/Holden Comprehensive Cancer Center is involved with conducting 639 clinical trials across 638 conditions. There are 42 research doctors associated with this hospital, such as David S. Dickens, Mariko Sato, Muhammad Furqan, and Yousef Zakharia, MD.
Where is University of Iowa/Holden Comprehensive Cancer Center located?
The University of Iowa Holden Comprehensive Cancer Center is situated at 200 Hawkins Dr., 7970 JPP, Iowa City, IA. For directions, take I-80 W to exit 242 for US-218 S toward Iowa City, continue on US-218 S to Dubuque St, turn right onto Dubuque St, and then left onto Hawkins Dr to reach the center.
Who should I call to ask about financial aid or insurance network?
**University of Iowa Hospitals & Clinics Financial and Billing Assistance:**
- To be eligible for financial assistance, individuals must:
- Be a documented resident of Iowa.
- Have an income at or below 350% of the Federal Income Poverty Guidelines.
- Provide proof of income.
- Comply with the Medicaid eligibility process with UI Health Care social workers or designated on-site representatives.
- For insurance-related questions, contact UI Health Care Financial Counseling at 319-338-2111.
- Holden Comprehensive Cancer Center offers oncology social workers to assist during the cancer treatment journey. For assistance, talk to your provider or call 1-800-777-8442. The financial management team ensures cancer treatments are covered by insurance, including preauthorization for medications and treatments.
What insurance does University of Iowa/Holden Comprehensive Cancer Center accept?
The University of Iowa/Holden Comprehensive Cancer Center accepts various insurance plans. Coverage details depend on the individual's insurance carrier and plan, so it's crucial to verify with your provider. Payments, including co-payments, can be made using Visa, MasterCard, Discover, or American Express.
What awards or recognition has University of Iowa/Holden Comprehensive Cancer Center received?
The Holden Comprehensive Cancer Center at the University of Iowa, recognized by the National Cancer Institute as a comprehensive cancer center since 2000, exemplifies excellence in cancer research and care. It has been awarded numerous grants, including SPORE grants for lymphoma and neuroendocrine tumors. The center's innovative MOGs program assembles multidisciplinary teams to offer personalized care, alongside a robust selection of clinical trials advancing cancer medicine.